Hemcheck and Capio S:t Göran’s hospital in a study on
reducing hemolysis in blood samples at the emergency care unit

Started October 2019 and has ended

Hemcheck Sweden AB and Capio S:t Göran’s Hospital have received approval from the Swedish Ethical Review Authority (EPN) to perform a study at Capio S:t Göran’s hospital emergency care unit to evaluate if Hemcheck’s product concept can lower the hemolysis rate in hemolysis sensitive blood samples sent to the central laboratory at Capio S:t Göran’s hospital.

The study is designed so that one part of the staff will use Hemcheck’s equipment for a limited time and then the result is compared against a control group where the equipment is not used.

“We look forward to this study where we hope we can show to Capio S:t Göran’s Hospital that our solution for point of care hemolysis detection can streamline blood sampling and greatly contribute to reducing the hemolysis rate in blood samples, and thus, among other things, can increase patient safety and quality of care. Together with Capio S:t Göran’s Hospital, we have chosen to seek EPN’s approval for this study in order to be able to collect more information than usual linked to the blood sampling and more easily follow up samples screened with our equipment, says Joen Averstad, CEO of Hemcheck.

“We are a forward-looking organization that constantly want to develop ourselves. As we see a problem with hemolysis in blood samples, we look forward to this study to build more knowledge about how we can handle the problem in a new way and to evaluate whether Hemcheck’s solution may be something we want to implement, says Göran Örnung, Head of the emergency medicine clinic at Capio S:t Göran’s Hospital.

Hemcheck is one of 13 selected companies to participate in the EU’s EIT Health initiative GoGlobal Canada

Started June 2019 and has ended


Following an intensive selection process through a dedicated European-Canadian jury, thirteen European companies are laureates of the 2019 edition of the GoGlobal Canada program and will benefit from a unique gateway to Canada. The program will enable the start-ups & SMEs to enter three recognised Canadian innovation hubs which can act as major stepping stones into the North American market and initiate significant collaboration opportunities with qualified stakeholders.

The programme will run over 2019 and is set up as followed:
– preparatory workshop for Canada during the European medtech event MedFIT, taking place during 25-26 June in Lille, France. It will be the opportunity for companies to meet the local partners and have a first level of understanding of the local market opportunities;

– a ten days’ immersion roadshow in the fall in British Columbia, Ontario and/or Quebec provinces to meet the local players (support structures, KOLs and potential partners), gain first visibility and traction and understand the local innovation trends and healthcare market access opportunities;

– final event and networking between the European and Canadian delegations during the MEDICA Fair in Düsseldorf, Germany, on 18-21 November to enable SMEs to share their experiences and benefit from an international outreach.

Read more about GoGlobal Canada and the selected companies.

Read more about EIT Health.